Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Vertex representative asks Senate committee for study of opioid-settlement funding and alternatives to opioids
Summary
Vertex Pharmaceuticals requested that the legislature consider study language to examine how opioid settlement funds are being used for prevention and education and to assess non-opioid alternatives for pain management; the behavioral health division explained the role of the opioid settlement committee and statutory limits on spending.
A representative of Vertex Pharmaceuticals asked a Senate committee to include study language examining the state's use of opioid settlement funds and how those funds are used for education about alternatives to opioid prescriptions.
Lacey Anderson, representing Vertex Pharmaceuticals, told the committee her company "manufacturers a non opioid that solves severe pain, issues" and asked lawmakers to consider study language to review what the opioid settlement fund is doing and how it educates clinicians and patients about non-opioid treatments. Anderson said the company's drug was…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
